Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**UBE2E1 antisense RNA 1 (UBE2E1-AS1)** is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the UBE2E1 gene locus on human chromosome 3[2][6]. Like other lncRNAs, UBE2E1-AS1 does not encode a protein and its biological role remains uncharacterized in current literature. Long non-coding RNAs generally participate in various regulatory functions, including chromatin remodeling, transcriptional and post-transcriptional gene regulation, often in a locus-specific manner[4]. UBE2E1-AS1’s potential function could involve modulation of the expression or splicing of its sense counterpart (UBE2E1), but direct evidence is lacking. No current evidence positions UBE2E1-AS1 as a therapeutic target, disease biomarker, or drug-interacting molecule; its significance remains primarily as a genomic feature[2][4][6].
Not established; as an lncRNA, possible mechanisms include chromatin modification, transcriptional regulation, or mRNA stability, but nothing specific documented for UBE2E1-AS1[4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UBE2E1 antisense RNA 1 (UBE2E1-AS1).